insights_auto
Why is 1AE up 3.51%?
Dive Deeperchevron_right
1AE:ETR
argenx SE
€730.40
arrow_upward
+3.51%(+24.80) 1D
Oct 9, 5:35:46 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 1AE...
Open
€738.00
High
€741.20
Low
€721.40
Mkt. cap
43.80B
Avg. vol.
78.00
Volume
221.00
P/E ratio
31.07
52-wk high
€922.00
52-wk low
€574.20
EPS
€23.51
No. of employees
2K
Open
€738.00
High
€741.20
Low
€721.40
Mkt. cap
43.80B
Avg. vol.
78.00
Volume
221.00
P/E ratio
31.07
52-wk high
€922.00
52-wk low
€574.20
EPS
€23.51
No. of employees
2K
News stories
From web sources and news partners
Simply Wall Street
·
1 day ago
Could A Halted Sjögren Trial Alter The Investment Case For argenx Stock?
Yahoo Finance
·
1 day ago
argenx (ENXTBR:ARGX) Stock May Be Fully Priced After Its 185% Run
AD HOC NEWS
·
1 day ago
Argenx stock sits at EUR 736.30 after a week of mixed trial news
Investing.com
·
2 days ago
H.C. Wainwright reiterates argenx stock buy rating on celiac drug data
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About argenx SE